Filed before 2025Filed 24 April 2017
Lyric Pharmaceuticals Inc. has sold $26.8M so far
Lyric Pharmaceuticals Inc., a pharmaceuticals company based in South San Francisco, CA, has sold $26.8M so far in its equity round, according to a filing dated 24 April 2017.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 24 April 2017
- First filed
- 26 February 2015
- Round
- Equity round (amended filing)
- Amount sold
- $26.8M
- Offering size
- $33.9M
- Investors so far
- 13
- Based in
- South San Francisco, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 87% of the 1,645 tracked raises with an amount filed in 2017, and than 72% of the 40 in pharmaceuticals.
Lyric Pharmaceuticals Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 24 Apr 2017 | Amended filing | $26.8M | This raise |
| 26 Feb 2015 | New filing | $7.81M | This raise |
More with 3x5 RiverVest on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.